LYRM4
LYR motif-containing protein 4
Also known as: C6orf149, CGI-203, ISD11, LYRM4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HD34
- Gene
- LYRM4
- Ensembl
- ENSG00000214113
- Chromosome
- 6
- Canonical length
- 91 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nuclear bodies
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is found in both mitochondria and the nucleus, where it binds cysteine desulfurase and helps free inorganic sulfur for Fe/S clusters. Disruption of this gene negatively impacts mitochondrial and cytosolic iron homeostasis. [provided by RefSeq, Sep 2016]
Canonical amino-acid sequenceUniProt
91 residues, UniProt reviewed canonical sequence.
>Q9HD34|LYRM4
1 MAASSRAQVL SLYRAMLRES KRFSAYNYRT YAVRRIRDAF RENKNVKDPV EIQTLVNKAK
61 RDLGVIRRQV HIGQLYSTDK LIIENRDMPR TLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LYRM4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- ovary: 29 nTPM
- pituitary gland: 27 nTPM
- choroid plexus: 26 nTPM
- cerebral cortex: 26 nTPM
- amygdala: 24 nTPM
- adrenal gland: 24 nTPM
Single-cell type
- choroid plexus epithelial cells: 183 nCPM
- late spermatids: 164 nCPM
- gastric progenitor cells: 137 nCPM
- differentiating spermatogonia: 132 nCPM
- lactotrophs: 130 nCPM
- esophageal basal cells: 129 nCPM
Immune cell
- myeloid DC: 35 nTPM
- memory B-cell: 31 nTPM
- naive CD4 T-cell: 27 nTPM
- naive B-cell: 26 nTPM
- naive CD8 T-cell: 25 nTPM
- NK-cell: 24 nTPM
Brain region
- cerebral cortex: 28 nTPM
- choroid plexus: 25 nTPM
- white matter: 24 nTPM
- medulla oblongata: 24 nTPM
- spinal cord: 24 nTPM
- pons: 23 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LYRM4.
Disease | AllUniProt
Conditions LYRM4 is implicated in, by any mechanism.
- Combined oxidative phosphorylation deficiency 19 (COXPD19) MIM:615595
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 104 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Combined oxidative phosphorylation deficiency 19
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.54
- gnomAD pLI
- 0.2
- gnomAD missense Z
- 0.36
- DepMap mean gene effect
- -1.22
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Complex 1 LYR protein domain
- Complex 1 protein (LYR family)
- LYRM4, LYR domain
- Iron-sulfur cluster assembly LYR protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LYRM4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LYRM4 as an antibody target. Whether an autoantibody or antibody against LYRM4 could matter depends on whether native LYRM4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LYRM4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LYRM4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...